Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA–Mediated Metabolic and Epigenetic Regulatory Networks
- 26 June 2023
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 21 (10) , 1079-1092
Abstract
Correlations between the oxidative stress response and metabolic reprogramming have been observed during malignant tumor formation; however, the detailed mechanism remains elusive. The transcription factor Nrf2, a master regulator of the oxidative stress response, mediates metabolic reprogramming in multiple cancers. In a mouse model of hepatocellular carcinoma (HCC), through metabolic profiling, genome-wide gene expression, and chromatin structure analyses, we present new evidence showing that in addition to altering antioxidative stress response signaling, Nrf2 ablation impairs multiple metabolic pathways to reduce the generation of acetyl-CoA and suppress histone acetylation in tumors, but not in tumor-adjacent normal tissue. Nrf2 ablation and dysregulated histone acetylation impair transcription complex assembly on downstream target antioxidant and metabolic regulatory genes for expression regulation. Mechanistic studies indicate that the regulatory function of Nrf2 is low glucose dependent, the effect of which is demolished under energy refeeding. Together, our results implicate an unexpected effect of Nrf2 on acetyl-CoA generation, in addition to its classic antioxidative stress response regulatory activity, integrates metabolic and epigenetic programs to drive HCC progression. Implications: This study highlights that Nrf2 integrates metabolic and epigenetic regulatory networks to dictate tumor progression and that Nrf2 targeting is therapeutically exploitable in HCC treatment.Keywords
All Related Versions
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (DK119762)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK105565)
- National Cancer Institute (CA062130)
- National Cancer Institute (CA132640)
This publication has 59 references indexed in Scilit:
- Glucose availability is a decisive factor for Nrf2-mediated gene expressionRedox Biology, 2013
- Targeting of Nrf2 induces DNA damage signaling and protects colonic epithelial cells from ionizing radiationProceedings of the National Academy of Sciences, 2012
- Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressorsGenes & Development, 2012
- Acetyl-CoA Induces Cell Growth and Proliferation by Promoting the Acetylation of Histones at Growth GenesMolecular Cell, 2011
- Regulation of chromatin by histone modificationsCell Research, 2011
- Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanismProceedings of the National Academy of Sciences, 2011
- ATP-Citrate Lyase Links Cellular Metabolism to Histone AcetylationScience, 2009
- Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytesJournal of Molecular and Cellular Cardiology, 2009
- NF-κB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafKBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2008
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006